Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytes

Abstract:
No abstract specified

SEEK ID: https://nextseek-dev.mit.edu/publications/15

PubMed ID: 39912921

DOI: 10.1084/jem.20241571

Projects: Published Data

Publication type: Journal

Journal: Journal of Experimental Medicine

Publisher: Rockefeller University Press

Citation: Journal of Experimental Medicine 222(4)

Date Published: 1st Feb 2025

URL: http://dx.doi.org/10.1084/jem.20241571

Registered Mode: imported from a bibtex file

Authors: Andrew W. Simonson, Joseph J. Zeppa, Allison N. Bucsan, Michael C. Chao, Supriya Pokkali, Forrest Hopkins, Michael R. Chase, Andrew J. Vickers, Matthew S. Sutton, Caylin G. Winchell, Amy J. Myers, Cassaundra L. Ameel, Ryan J. Kelly, Ben Krouse, Luke E. Hood, Jiaxiang Li, Chelsea C. Lehman, Megha Kamath, Jaime Tomko, Mark A. Rodgers, Rachel Donlan, Harris Chishti, H. Jacob Borish, Edwin Klein, Charles A. Scanga, Sarah M. Fortune, Philana Ling Lin, Pauline Maiello, Mario Roederer, Patricia A. Darrah, Robert A. Seder, JoAnne L. Flynn

help Submitter
Citation
Simonson, A. W., Zeppa, J. J., Bucsan, A. N., Chao, M. C., Pokkali, S., Hopkins, F., Chase, M. R., Vickers, A. J., Sutton, M. S., Winchell, C. G., Myers, A. J., Ameel, C. L., Kelly, R. J., Krouse, B., Hood, L. E., Li, J., Lehman, C. C., Kamath, M., Tomko, J., … Flynn, J. A. L. (2025). Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytes. In Journal of Experimental Medicine (Vol. 222, Issue 4). Rockefeller University Press. https://doi.org/10.1084/jem.20241571
Activity

Views: 25

Created: 25th Aug 2026 at 16:29

Last updated: 25th Aug 2026 at 18:40

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.15.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH